Literature DB >> 32119831

Coronavirus outbreak: the role of companies in preparedness and responses.

Marc Fadel1, Jérôme Salomon2, Alexis Descatha3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32119831      PMCID: PMC7129529          DOI: 10.1016/S2468-2667(20)30051-7

Source DB:  PubMed          Journal:  Lancet Public Health


× No keyword cloud information.
As in previous health crises, the coronavirus disease 2019 (COVID-19) outbreak has raised questions about preparedness and emergency responses in many countries. In this crisis, what role can companies play? Public and private companies must continue to produce or provide their services, but with consideration of the health context. Many companies are involved with the COVID-19 outbreak because they are established in or work with China (client or supplier), and most have already activated their business continuity planning or equivalent. During an infectious disease outbreak like COVID-19, most large companies around the world have a major part to play, especially in terms of preparedness and emergency response. Indeed, companies should be integrated into the governmental health contingency plan developed in many countries, and by WHO and the International Labor Organization.1, 2, 3 Helped by their occupational practitioners, healthcare advisers, and safety professionals, companies that have a financial capacity and responsibilities (including governmental, federal, or state administrations) will thus have to prepare their business continuity planning for when cases of infected patients occur in the company. They also must be prepared for the potential psychosocial and psychological effects of outbreaks. All health professionals should be involved in the development and implementation of recommendations for companies and their environments. In practice, based on previous outbreak experiences and governmental contingency plans integrating workplaces as recommended by various organisations,1, 2, 3 specific actions should be taken. First, prevention of discrimination of Chinese workers is crucial, as potential fears could arise around possible infectious cases, whether confirmed or not. Second, teleworking should be encouraged and developed. Third, we recommend that companies implement a dedicated response with medical screening, surveillance, and care, including psychological support. Companies are responsible for provision of optimal prevention to protect the health of their employees during their work. Fourth, regular follow-up of workers can also be done using telemedicine by the occupational health service to reduce in-person contact. Fifth, training and information on the responsibility of each employee in prevention of disease should be provided by health practitioners, such as basic hygiene rules and mask use. Finally, specific support for returning to work should be implemented, including assessment for eligibility for employment injury benefit. These recommendations should be included in occupational risk assessment. Companies are and will be an important piece of global management of any outbreaks, including COVID-19, through the crucial involvement of their occupational, health, and safety practitioners.
  1 in total

1.  A contingency plan for healthcare worker protection in the event of a flu pandemic.

Authors:  Alexis Descatha; François Dolveck; Jérome Salomon
Journal:  J Occup Environ Med       Date:  2006-07       Impact factor: 2.162

  1 in total
  12 in total

Review 1.  A Review of the Strategies and Studies on the Prevention and Control of the New Coronavirus in Workplaces.

Authors:  Ehsan Rafeemanesh; Fatemeh Ahmadi; Maryam Memarzadeh
Journal:  Arch Bone Jt Surg       Date:  2020-04

2.  Competing during a pandemic? Retailers' ups and downs during the COVID-19 outbreak.

Authors:  Eleonora Pantano; Gabriele Pizzi; Daniele Scarpi; Charles Dennis
Journal:  J Bus Res       Date:  2020-05-21

3.  Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study.

Authors:  Fan-Yun Lan; Chih-Fu Wei; Yu-Tien Hsu; David C Christiani; Stefanos N Kales
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

4.  Working from home in the time of COVID-19: how to best preserve occupational health?

Authors:  Hanifa Bouziri; David R M Smith; Alexis Descatha; William Dab; Kevin Jean
Journal:  Occup Environ Med       Date:  2020-04-30       Impact factor: 4.402

5.  Ensuring Business Continuity of Musculoskeletal Care During the COVID-19 Pandemic: Experience of a Tertiary Orthopaedic Surgery Department in Singapore.

Authors:  Ming Han Lincoln Liow; Kenny Xian Khing Tay; Nicholas Eng Meng Yeo; Darren Keng Jin Tay; Seo Kiat Goh; Joyce Suang Bee Koh; Tet Sen Howe; Andrew Hwee Chye Tan
Journal:  JB JS Open Access       Date:  2020-05-15

6.  From Preparedness to Recovery: Learning Lessons Of COVID-19 Outbreak from China.

Authors:  Charles Nsanzabera; Leonard Ndayisenga; Jean Damascene Kabakambira; Felix Hagenimana
Journal:  East Afr Health Res J       Date:  2020-06-26

7.  The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.

Authors:  Milad Haghani; Michiel C J Bliemer; Floris Goerlandt; Jie Li
Journal:  Saf Sci       Date:  2020-05-07       Impact factor: 6.392

8.  Occupational health responses to COVID-19: What lessons can we learn from SARS?

Authors:  David Koh; Hui Poh Goh
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

9.  Adjusting working conditions and evaluating the risk of infection during the COVID-19 pandemic in different workplace settings in Germany: a study protocol for an explorative modular mixed methods approach.

Authors:  Esther Rind; Klaus Kimpel; Christine Preiser; Falko Papenfuss; Anke Wagner; Karina Alsyte; Achim Siegel; Antje Klink; Benjamin Steinhilber; Johanna Kauderer; Monika A Rieger
Journal:  BMJ Open       Date:  2020-11-18       Impact factor: 2.692

10.  Responsible Communication of Romanian Companies for Ensuring Public Health in a COVID-19 Pandemic Context.

Authors:  Camelia-Daniela Hategan; Ruxandra-Ioana Curea-Pitorac; Vasile-Petru Hategan
Journal:  Int J Environ Res Public Health       Date:  2020-11-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.